Swedish Orphan Biovitrum, also known as Sobi, has published a new analysis of Elocta (rFVIIIFc-efmoroctog alfa) for hemophilia A in The Journal of Blood Medicine. 26 March 2021
Pieris Pharmaceuticals has received a $13 million equity investment from Seagen, as part of an ongoing collaboration between the two companies. 25 March 2021
French biotech Step Pharma, which is developing new drugs for oncology and autoimmune diseases, has announced the successful closing of a 35 million euros ($41.5 million) Series B financing. 24 March 2021
Eisai has won Japanese approval for Remitoro (denileukin diftitox) to treat relapsed or refractory peripheral T-cell lymphoma (PTCL) and relapsed or refractory cutaneous T-cell lymphoma (CTCL). 23 March 2021
Late Monday, the US Data and Safety Monitoring Board (DSMB) notified the NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial. 23 March 2021
Søren Bregenholt will become chief executive officer of Alligator Bioscience from June, with current COO Malin Carlsson taking over as interim CEO to facilitate the transition. 19 March 2021
Data from a Phase III extension study shows that Tremfya (guselkumab) maintains joint efficacy and complete skin clearance in adults with active psoriatic arthritis (PsA) through two years. 16 March 2021
Adding to its European Commission conditional marketing authorization just a day earlier, the World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen, the prescription pharma unit of US healthcare giant Johnson & Johnson, for emergency use in all countries and for COVAX roll-out. 12 March 2021
Japanese drugmaker Daiichi Sankyo has started manufacturing COVID-19 Vaccine AstraZeneca in the country, under the terms of an outsourcing agreement. 12 March 2021
UK pharma major GlaxoSmithKline has said it will expand its manufacturing capability for cell and gene therapies using the Cell and Gene Therapy Catapult’s large scale manufacturing facility in Stevenage, UK. 11 March 2021
A new partnership between The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines will seek to develop vaccine candidates against coronavirus variants. 11 March 2021
UK-based biotech Enara Bio has announced new appointments to its senior research team, bringing specialized expertise and leadership in immunotherapy. 9 March 2021
In a move that appears to be condoned by the European Commission, the Italian government has blocked the export of COVID-19 Vaccine AstraZeneca, the Oxford University-developed jab that is being commercialized by US pharma major AstraZeneca. 5 March 2021
Biopharma company Akari Therapeutics has announced a cooperative research and development agreement with the US Army Institute of Surgical Research to evaluate the use of nomacopan in civilian and battlefield trauma for which there are currently no approved therapies. 5 March 2021
The US Food and Drug Administration granted regular approval to lorlatinib for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, detected by an FDA-approved test. 4 March 2021
Newly-launched Bionaut Labs has raised $20 million in a financing round led by Khosla Ventures. The firm will focus on developing precision medicine treatments for CNS disorders. 4 March 2021
Pharmaron, a China-based R&D service provider for the pharmaceutical and biotech industries has entered into a definitive agreement to acquire Allergan Biologics Limited (ABL) in Liverpool, UK. 3 March 2021
Italian pharma major Recordati saw its shares rise more than 5% to 52.00 euros in early trading, as it announced a deal to expand its portfolio of marketed rare disease medicines. 4 October 2024
Paris-based asset manager Kurma Partners has raised 140 million euros ($154 million), successfully completing the first closing of Biofund IV 4 October 2024
Bristol Myers Squibb has received a new approval from the US Food and Drug Administration for its blockbuster checkpoint blocker, Opdivo (nivolumab). 4 October 2024
Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to collaborate on advancing health and sustainability outcomes in Singapore and the broader Asia Pacific region. 4 October 2024
The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC 1001), an investigational treatment designed to address the root cause of myotonic dystrophy type 1 (DM1), under development by US biotech Avidity Biosciences . 4 October 2024
The US Food and Drug Administration (FDA) has granted the Gilead Sciences subsidiary Kite a Regenerative Medicine Advanced Therapy Designation (RMAT) for Yescarta (axicabtagene ciloleucel) for adults with newly-diagnosed, high-risk large B-cell lymphoma (LBCL). 3 October 2024
Kedrion Biopharma has finalized an agreement with Germany-based Biotest for the long-term commercialization and distribution of Yimmugo (immune globulin) in the USA. 3 October 2024
US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer treatments. 3 October 2024
PeptiDream says that its wholly-owned PDRadiopharma subsidiary has entered into a strategic partnership with French nuclear medicines firm Curium. 3 October 2024
Privately-held Ferring Pharmaceuticals has announced the opening of a global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin (nadofaragene firadenovec-vncg). 3 October 2024
Shares of UK drug developer Hemogenyx Pharmaceuticals rose as much as 9% and closed up 5.9% at 1.70 pence yesterday on the news of a further investment from Prevail Partners. 3 October 2024
UK-based biotech Resolution Therapeutics has announced the completion of a £63.5 million ($76.8 million) series B financing round led by Syncona. 3 October 2024
The BioIndustry Association (BIA), in collaboration with the Centre for Process Innovation (CPI), has published a new report on the UK’s mRNA sector. 2 October 2024
Aspen Neuroscience, a private biotechnology company specializing in autologous cell therapies, has announced the opening of a major new facility near its headquarters in San Diego. 2 October 2024
Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024